Oral adjuvanted Vibrio vaccine enhances antibody production and lysozyme activity in the serum and mucus of marine-cultured red hybrid tilapia (Oreochromis sp.) against V. harveyi and V. alginolyticus.

Documenti analoghi

• Identification of a conserved cryptic epitope with cross-immunoreactivity in outer membrane protein K (OmpK) from Vibrio species.
  di: Lun, Jingsheng, et al.
  Pubblicazione: (2025)
• The roles of the BarA-UvrY two-component system in the virulence of Vibrio harveyi and the efficacy evaluation of mutant strains ΔbarA and ΔuvrY as live-attenuated vaccines.
  di: Zhang, Yilin, et al.
  Pubblicazione: (2026)
• Vaccines as a strategic approach to combat Vibrio parahaemolyticus and control of early mortality syndrome sin shrimp aquaculture: A comprehensive review.
  di: Sen, Bipul Kumar, et al.
  Pubblicazione: (2026)
• Application of a Rationally Designed Mucosal Nanovaccine Platform in Bacterial Disease Prophylactics Using Fish as a Model Organism.
  di: Zhang, Chen, et al.
  Pubblicazione: (2025)
• Construction and analysis of the immune effect of subunit vaccines based on the flagellin FlaB and FlaC of Vibrioharveyi.
  di: Zhang, Han, et al.
  Pubblicazione: (2025)